Julian A. Symons - Executive Vice President, Chief Scientific Officer at Aligos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, Chief Scientific Officer
Stock Symbol
ALGS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julian A. Symons since 12/18/2023

Holdings reported by Julian A. Symons for Aligos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 10.9K Sep 4, 2024 Direct Common Stock

Transactions reported by Julian A. Symons for Aligos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.